IMCURE THERAPEUTICS
Similar Organizations
Adriacell
Anti-tumor therapeutics
Pathfinder Therapeutics
Pathfinder Therapeutics
Senexta Therapeutics
Senexta Therapeutics
More informations about "ImCure Therapeutics"
ImCure Therapeutics Company Profile 2024: Valuation, …
ImCure Therapeutics General Information Description. Developer of cardiovascular and arthritis treatments. The company develops drugs and other water-soluble cholesterol altering compounds for treating cardiovascular and …See details»
ImCure Therapeutics - Crunchbase Company Profile & Funding
Alternatives and possible competitors to ImCure Therapeutics may include Diorasis Therapeutics, GeneSegues Therapeutics, and Pathfinder Therapeutics. Unlock even more features with …See details»
Imcure Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Nov 8, 2024 Explore Imcure Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:184045 (Imcure Therapeutics, Inc.).See details»
184045 (Imcure Therapeutics, Inc.) - Drug Targets, Indications, …
184045 (Imcure Therapeutics, Inc.), Initially developed by Imcure Therapeutics, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Infectious Diseases. ... Originator …See details»
Home | iECURE
May 7, 2024 Our mutation-agnostic in vivo insertion methods knock in healthy copies of disease-causing genes, offering long-term, stable expression of those genes in patients. To accomplish this, we work hand-in-hand with the …See details»
Joseph Rubinfeld Ph.D Profile: Contact Information & Network
May 30, 1997 Dr. Joseph Rubinfeld is the Founder of ImCure Therapeutics. He served as Independent Director at International Infusion. He is the Founder of JJ Pharma. He served as …See details»
ImCure Therapeutics - Crunchbase
Edit Similar Companies Section. Companies like ImCure Therapeutics include ImCure Therapeutics includeSee details»
NextCure, Inc.
9000 Virginia Manor Road | Suite 200 | Beltsville, MD 20705 | USA | (240) 399-4900See details»
Emcure Pharmaceuticals - Crunchbase Company Profile …
Emcure was born out of the vision to create a healthcare company that would address the vast healthcare needs. They commitment and drive have propelled our growth from a single manufacturing facility during the genesis, to a range …See details»
iECURE Secures Clearance from Australian Therapeutic Goods ...
Dec 13, 2023 ECUR-506 is a gene editing-based investigational therapy for the treatment of Ornithine Transcarbamylase (OTC) deficiency . PHILADELPHIA— Dec. 13, 2023 – iECURE, …See details»
iECURE Launches With $50 Million Series A Financing to Develop …
September 9, 2021. PHILADELPHIA—(BUSINESS WIRE)—iECURE (pronounced EE-ah-cure), a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high …See details»
iECURE Announces FDA Clearance of Investigational New Drug …
PHILADELPHIA, April 04, 2024--iECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene insertion, or knock-in, editing therapies for the …See details»
Meet the Leadership Team | Emcure Pharmaceuticals
Sanjay Singh Chief Executive Officer & Whole-time Director – Gennova Biopharmaceuticals LimitedSee details»
About Us | Emcure Pharmaceuticals
Sep 30, 2023 Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive …See details»
1:24-cv-01363 | Heron Therapeutics, Inc. v. Azurity Pharmaceuticals ...
Parties, patents and docket of Heron Therapeutics Inc. v. Azurity Pharmaceuticals Inc. and 2 other defendants (1:24-cv-01363) from District of Delaware filed on 12/12/2024See details»
AMERICAN REGENT, INC. v. SOMERSET THERAPEUTICS, LLC et al DC
5 days ago Parties, patents and docket of American Regent Inc. v. Odin Pharmaceuticals LLC and 2 other defendants (2:24-cv-11124) from District of New Jersey filed on 12/13/2024See details»
Emcure Pharma IPO: All you need to know | Value Research
Jul 2, 2024 It is the market leader in the gynaecology and HIV antiviral therapeutics, and is among the top 10 players in five other therapeutic areas in terms of market share. Vertical …See details»
Global Presence | Emcure Pharmaceuticals
Emcure has established its presence in over 70 locations globally, with strategic partnerships with multi-national companies while offering expertise in biologics, Novel Drug Delivery Systems, …See details»
Emcure Pharmaceuticals | Leading Global Pharmaceutical Company
Emcure Pharmaceuticals Limited was built with the purpose and core belief of making E ffective M edicines to Cure patients enabling them to lead healthier lives. We are one of the leading …See details»
Bain-backed Emcure Pharmaceuticals eyes $672 mln IPO - source
Aug 19, 2021 India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, which a source with direct knowledge of the matter said could be …See details»